![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/00 | |
A61K 47/36 | |||
A61K 47/42 | |||
A61K 39/00 | |||
A61K 39/395 | |||
C07K 16/00 | |||
C07K 16/06 | |||
C12N 9/24 |
(11) | Number of the document | 2477603 |
(13) | Kind of document | T |
(96) | European patent application number | 10760140.3 |
Date of filing the European patent application | 2010-09-16 | |
(97) | Date of publication of the European application | 2012-07-25 |
(45) | Date of publication and mention of the grant of the patent | 2016-03-30 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2010/002545 |
Date | 2010-09-16 |
(87) | Number | WO 2011/034604 |
Date | 2011-03-24 |
(30) | Number | Date | Country code |
277045 P | 2009-09-17 | US |
(72) |
TESCHNER, Wolfgang, AT
SVATOS, Sonja, AT
BRUCKSCHWAIGER, Leopold, AT
WEBER, Alfred, AT
SCHWARZ, Hans-Peter, AT
LEI, Laura, US
|
(73) |
Baxalta GmbH,
Thurgauerstrasse 130, 8152 Glattpark, Opfikon,
CH
Baxalta Incorporated, 1200 Lakeside Drive, Bannockburn, IL 60015, US |
(54) | STABLE CO-FORMULATION OF HYALURONIDASE AND IMMUNOGLOBULIN, AND METHODS OF USE THEREOF |
STABLE CO-FORMULATION OF HYALURONIDASE AND IMMUNOGLOBULIN, AND METHODS OF USE THEREOF |